The Journal of ExtraCorporeal Technology No 56-4 | Page 76

214 G . Budhu et al .: J Extra Corpor Technol 2024 , 56 , 211 – 215
TPE can induce severe coagulopathy if albumin is used for replacement instead of FFP , requiring close monitoring of coagulation factors .
In the cases presented , TPE was set up with the typical anticoagulant , citrate [ 17 ] in the blood-to-citrate ratio of 15:1 to achieve interface sooner . Subsequently , citrate was replaced by 0.9 % NaCl to minimize the risk of intracranial bleeding in already systemically heparinized patients . We also wanted to avoid hypocalcemia , a relatively frequent complication . In a study of 76 patients , out of which 53 were children , hypocalcemia was noted in 27.6 % of patients [ 7 ]. Our approach led to an overall reduction in the average TPE time without significant coagulation derangement , and the total citrate received was kept at a minimum . The TPE resulted in a sustained reduction of PFH and , thereby , in hemolysis and morbid sequelae . Though clinical outcomes were poor in both cases , the desired effect of reduction in hemolysis was achieved ( NB . data is accrued continuously ).
Given the wide range of incidence of ECMO-induced hemolysis , we interrogated the 2023 ELSO report with respect to infants ( defined as < 28 days old ) and found out that for the subpopulation with cardiac disease requiring ECMO , severe hemolysis ( defined as PFH > 100 ) was reported in 54 / 366 cases ( 14.8 %) with 28 % survival rate . In turn , for those with respiratory illnesses requiring ECMO , in the same time period , there were 67 / 475 cases of severe hemolysis ( 14.1 %), with a 43 % survival rate .
We conclude that TPE plays a role in managing severe ECMO-induced hemolysis and is feasible to be used in tandem with ECMO in infants and older children . In the absence of randomized studies to date , a database of patients experiencing ECMO-induced hemolysis should be set up , with the scope of creating clinical practice guidelines for adequate therapy . After ensuring cannulae are in the first line of therapy for severe correct position and void of thrombi or fibrin deposition , we could recommend TPE as the first line of therapy for severe ECMO-induced hemolysis . We also emphasize the importance of continuous monitoring of hemodynamics , urine output , ionized calcium , and blood gases during the procedure .
Acknowledgements We thank the Medical staff involved in the care of these patients .
Funding The authors received no funding to complete this research .
Conflicts of interest The authors declare no conflict of interest .
Data availability statement All pertinent data are included in the manuscript .
Author contribution statement
GB and KM-W – data analysis , creation of graphs , and manuscript preparation .
ARC – conceptualize and editing .
Ethics approval Ethics guidelines were respected in this case report .
References
1 . Dufour N , Radjou A , Thuong M . Hemolysis and plasma free hemoglobin during extracorporeal membrane oxygenation support : from clinical implications to laboratory details . ASAIO J . 2020 ; 66 ( 3 ): 239 – 246 .
2 . Shakoor A , Zenilman A , DeFazio J , Li L , Neunert C , Kadenhe- Chiweshe A . Therapeutic modalities for management of hemolysis in pediatric extracorporeal membrane oxygenation ( ECMO ). J Clin Res Med . 2018 ; 1 ( 3 ): 1 – 3 .
3 . Okochi S , Cheung EW , Barton S , et al . An Analysis of risk factors for hemolysis in children on extracorporeal membrane oxygenation . Pediatr Crit Care Med . 2018 ; 19:1059 – 1066 .
4 . Williams DC , Turi JL , Hornik CP , et al . Circuit oxygenator contributes to extracorporeal membrane oxygenation-induced hemolysis . ASAIO J . 2015 ; 61 ( 2 ): 190 – 195 .
5 . Lequier L , Horton SB , McMullan DM , Bartlett RH . Extracorporeal membrane oxygenation circuitry . Pediatr Crit Care Med . 2013 ; 14 ( 5 Suppl 1 ); S7 – 12 .
6 . Pan KC , McKenzie DP , Pellegrino V , Murphy D , Butt W . The meaning of a high plasma free hemoglobin : retrospective review of the prevalence of hemolysis and circuit thrombosis in an adult ECMO centre over 5 years . Perfusion . 2016 ; 31 ( 3 ): 223 – 231 .
7 . Lerner RK , Pollack U . The use of therapeutic plasma exchange for pediatric patients supported on extracorporeal membranous oxygenator therapy : a narrative review . Perfusion . 2022 ; 37 : 113 – 122 .
8 . Houston S , Patel S , Badheka A , Lee-Son K . Clearance of severely elevated plasma free hemoglobin with total plasma exchange in a pediatric ECMO patient . Perfusion . 2022 ; 37:515 – 518 .
9 . Calvaresi EC , La ’ ulu SL , Snow TM , Allison TR , Genzen JR . Plasma hemoglobin : a method comparison of six assays for hemoglobin and hemolysis index measurement . Int J Lab Hematol . 2021 ; 43 ( 5 ): 1145 – 153 .
10 . Constantinescu AR , Smith P , Blair J , Qbeiwi RR . Plasma exchange therapy in an infant : proposing a new anticoagulation protocol . J Urol Ren Dis . 2022 ; 07:1247 .
11 . Skogby M , Mellgren K , Friberg LG , Chevalier JY , Mellgren G . Induced cell trauma during in vitro perfusion : a comparison of two different perfusion systems . Artif Organs . 1998 ; 22 ( 12 ): 1045 – 1051 .
12 . Rother RP , Bell L , Hillmen P , Gladwin MT . The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin : a novel mechanism of human diseaseJAMA . 2005 ; 293 ( 13 ): 1653 – 1662 .
13 . Lou S , MacLaren G , Best D , Delzoppo C , Butt W . Hemolysis in pediatric patients receiving centrifugal-pump extracorporeal membrane oxygentation : prevalence , risk factors , and outcomes . J Extra Corpor Technol . 2014 ; 42 ( 5 ): 1213 – 1220 .
14 . Gbadegesin R , Zhao S , Charpie J , Brophy PD , Smoyer WE , Lin JJ . Significance of hemolysis on extracorporeal life support after cardiac surgery in children . Pediatr Nephrol . 2009 ; 24:589 – 595 .
15 . Cortina G , McRae R , Chiletti R , Butt W . Therapeutic plasma exchange in critically ill children requiring intensive care . Pediatr Crit Care Med . 2018 ; 19 ( 2 ): e97 – e104 .